A citation-based method for searching scientific literature

Milda R Saunders, Adam Cifu, Monica Vela. JAMA 2015
Times Cited: 22







List of co-cited articles
147 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Cost-effectiveness of primary screening for CKD: a systematic review.
Paul Komenda, Thomas W Ferguson, Kerry Macdonald, Claudio Rigatto, Chris Koolage, Manish M Sood, Navdeep Tangri. Am J Kidney Dis 2014
96
22

A new equation to estimate glomerular filtration rate.
Andrew S Levey, Lesley A Stevens, Christopher H Schmid, Yaping Lucy Zhang, Alejandro F Castro, Harold I Feldman, John W Kusek, Paul Eggers, Frederick Van Lente, Tom Greene,[...]. Ann Intern Med 2009
18


Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.
Alan S Go, Glenn M Chertow, Dongjie Fan, Charles E McCulloch, Chi-yuan Hsu. N Engl J Med 2004
18

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.
Kunihiro Matsushita, Marije van der Velde, Brad C Astor, Mark Woodward, Andrew S Levey, Paul E de Jong, Josef Coresh, Ron T Gansevoort. Lancet 2010
18



The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report.
Andrew S Levey, Paul E de Jong, Josef Coresh, Meguid El Nahas, Brad C Astor, Kunihiro Matsushita, Ron T Gansevoort, Bertram L Kasiske, Kai-Uwe Eckardt. Kidney Int 2011
18

Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury.
Ravindra L Mehta, John A Kellum, Sudhir V Shah, Bruce A Molitoris, Claudio Ronco, David G Warnock, Adeera Levin. Crit Care 2007
13

Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate.
Kunihiro Matsushita, Bakhtawar K Mahmoodi, Mark Woodward, Jonathan R Emberson, Tazeen H Jafar, Sun Ha Jee, Kevan R Polkinghorne, Anoop Shankar, David H Smith, Marcello Tonelli,[...]. JAMA 2012
618
13

Chronic kidney disease: global dimension and perspectives.
Vivekanand Jha, Guillermo Garcia-Garcia, Kunitoshi Iseki, Zuo Li, Saraladevi Naicker, Brett Plattner, Rajiv Saran, Angela Yee-Moon Wang, Chih-Wei Yang. Lancet 2013
13


Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts.
Ron T Gansevoort, Kunihiro Matsushita, Marije van der Velde, Brad C Astor, Mark Woodward, Andrew S Levey, Paul E de Jong, Josef Coresh. Kidney Int 2011
460
9


Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts.
Brad C Astor, Kunihiro Matsushita, Ron T Gansevoort, Marije van der Velde, Mark Woodward, Andrew S Levey, Paul E de Jong, Josef Coresh, Brad C Astor, Kunihiro Matsushita,[...]. Kidney Int 2011
439
9

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate.
Andrew S Levey, Josef Coresh, Tom Greene, Lesley A Stevens, Yaping Lucy Zhang, Stephen Hendriksen, John W Kusek, Frederick Van Lente. Ann Intern Med 2006
9

Early recognition and prevention of chronic kidney disease.
Matthew T James, Brenda R Hemmelgarn, Marcello Tonelli. Lancet 2010
351
9

Screening for, monitoring, and treatment of chronic kidney disease stages 1 to 3: a systematic review for the U.S. Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline.
Howard A Fink, Areef Ishani, Brent C Taylor, Nancy L Greer, Roderick MacDonald, Dominic Rossini, Sameea Sadiq, Srilakshmi Lankireddy, Robert L Kane, Timothy J Wilt. Ann Intern Med 2012
166
9

Assessment of glomerular filtration rate in the neonate: is creatinine the best tool?
Guido Filler, Ricardo Guerrero-Kanan, Ana Catalina Alvarez-Elías. Curr Opin Pediatr 2016
24
9

Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature.
Fabian A Mendoza, Carol M Artlett, Nora Sandorfi, Kevin Latinis, Sonsoles Piera-Velazquez, Sergio A Jimenez. Semin Arthritis Rheum 2006
193
9

Large sample of nephrogenic systemic fibrosis cases from a single institution.
Christine U Lee, Christina M Wood, Gina K Hesley, Nelson Leung, Mellena D Bridges, Jeffrey T Lund, Peter U Lee, Mark R Pittelkow. Arch Dermatol 2009
17
11

Is this really a true case of NSF following Gadovist exposure alone?
Tara Collidge, Peter Thomson, Patrick Mark, Winfried Willinek, Giles Roditi. Nephrol Dial Transplant 2010
9
22

Extracellular Gd-CA: differences in prevalence of NSF.
Henrik S Thomsen, Peter Marckmann. Eur J Radiol 2008
52
9

NSF after Gadovist exposure: a case report and hypothesis of NSF development.
Helmut Wollanka, Werner Weidenmaier, Cecylia Giersig. Nephrol Dial Transplant 2009
35
9

Renal safety of intravenous gadolinium-enhanced magnetic resonance imaging in patients awaiting liver transplantation.
Katherine M Shaffer, Mehul R Parikh, Thomas M Runge, Sebastian D Perez, Sonali S Sakaria, Ram M Subramanian. Liver Transpl 2015
9
22

Acute kidney injury: epidemiology and diagnostic criteria.
Eric A J Hoste, John A Kellum. Curr Opin Crit Care 2006
134
9


Nephrogenic systemic fibrosis is found only among gadolinium-exposed patients with renal insufficiency: a case-control study from Denmark.
T R Elmholdt, M Pedersen, B Jørgensen, K Søndergaard, J D Jensen, M Ramsing, A B Olesen. Br J Dermatol 2011
33
9

Gadobutrol in Renally Impaired Patients: Results of the GRIP Study.
Henrik J Michaely, Manuela Aschauer, Hannes Deutschmann, Georg Bongartz, Matthias Gutberlet, Ramona Woitek, Birgit Ertl-Wagner, Walter Kucharczyk, Renate Hammerstingl, Francesco De Cobelli,[...]. Invest Radiol 2017
27
9


Nephrogenic systemic fibrosis: clinicopathological definition and workup recommendations.
Michael Girardi, Jonathan Kay, Dirk M Elston, Philip E Leboit, Ali Abu-Alfa, Shawn E Cowper. J Am Acad Dermatol 2011
108
9

Safety of gadobutrol in more than 1,000 pediatric patients: subanalysis of the GARDIAN study, a global multicenter prospective non-interventional study.
Katja Glutig, Ravi Bhargava, Gabriele Hahn, Wolfgang Hirsch, Christian Kunze, Hans-Joachim Mentzel, Jürgen F Schaefer, Winfried Willinek, Petra Palkowitsch. Pediatr Radiol 2016
21
9

Nephrogenic systemic fibrosis: risk factors and incidence estimation.
Elizabeth A Sadowski, Lindsey K Bennett, Micah R Chan, Andrew L Wentland, Andrea L Garrett, Robert W Garrett, Arjang Djamali. Radiology 2007
638
9

Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging.
Robert J McDonald, Jennifer S McDonald, David F Kallmes, Mark E Jentoft, David L Murray, Kent R Thielen, Eric E Williamson, Laurence J Eckel. Radiology 2015
781
9

Observational study on the safety profile of gadoterate meglumine in 35,499 patients: The SECURE study.
Philippe Soyer, Anthony Dohan, Deepak Patkar, Andreas Gottschalk. J Magn Reson Imaging 2017
32
9

Prospective Cohort Study of Nephrogenic Systemic Fibrosis in Patients With Stage 3-5 Chronic Kidney Disease Undergoing MRI With Injected Gadobenate Dimeglumine or Gadoteridol.
Gilles Soulez, Daniel C Bloomgarden, Neil M Rofsky, Martin P Smith, Hani H Abujudeh, Desiree E Morgan, Richard J Lichtenstein, Mark L Schiebler, Franz J Wippold, Craig Russo,[...]. AJR Am J Roentgenol 2015
42
9

Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines.
Henrik S Thomsen, Sameh K Morcos, Torsten Almén, Marie-France Bellin, Michele Bertolotto, Georg Bongartz, Olivier Clement, Peter Leander, Gertraud Heinz-Peer, Peter Reimer,[...]. Eur Radiol 2013
256
9

Safety of meglumine gadoterate (Gd-DOTA)-enhanced MRI compared to unenhanced MRI in patients with chronic kidney disease (RESCUE study).
Gilbert Deray, Olivier Rouviere, Lorenzo Bacigalupo, Bart Maes, Thierry Hannedouche, François Vrtovsnik, Claire Rigothier, Jean-Marie Billiouw, Paolo Campioni, Joaquin Ferreiros,[...]. Eur Radiol 2013
32
9

Gadolinium-based contrast agents: A comprehensive risk assessment.
Tyler J Fraum, Daniel R Ludwig, Mustafa R Bashir, Kathryn J Fowler. J Magn Reson Imaging 2017
138
9

Nephrogenic systemic fibrosis: what the hospitalist needs to know.
Derek M Fine, Mark A Perazella. J Hosp Med 2010
5
40

Incidence of Nephrogenic Systemic Fibrosis Using Gadobenate Dimeglumine in 1423 Patients With Renal Insufficiency Compared With Gadodiamide.
Richard Bruce, Andrew L Wentland, Anna K Haemel, Robert W Garrett, Donna R Sadowski, Arjang Djamali, Elizabeth A Sadowski. Invest Radiol 2016
30
9

Prevalence of nephrogenic systemic fibrosis in renal insufficiency patients: results of the FINEST study.
Nicolas Janus, Vincent Launay-Vacher, Svetlana Karie, Olivier Clement, Elena Ledneva, Camille Frances, Gabriel Choukroun, Gilbert Deray. Eur J Radiol 2010
38
9

Nephrogenic systemic fibrosis: a clinicopathologic study of 6 cases.
Jennifer G Pryor, Glynis A Scott. J Am Acad Dermatol 2007
15
13


Pharmacokinetics, dose proportionality, and tolerability of gadobutrol after single intravenous injection in healthy volunteers.
T Staks, G Schuhmann-Giampieri, T Frenzel, H J Weinmann, L Lange, J Platzek. Invest Radiol 1994
106
9

Nephrogenic systemic fibrosis: change in incidence following a switch in gadolinium agents and adoption of a gadolinium policy--report from two U.S. universities.
Ersan Altun, Diego R Martin, Rebecca Wertman, Aida Lugo-Somolinos, Edwin R Fuller, Richard C Semelka. Radiology 2009
89
9


Safety of gadobutrol in over 23,000 patients: the GARDIAN study, a global multicentre, prospective, non-interventional study.
Martin R Prince, Hae Giu Lee, Chang-Hee Lee, Sung Won Youn, In Ho Lee, Woong Yoon, Benqiang Yang, Haiping Wang, Jin Wang, Tiffany Ting-Fang Shih,[...]. Eur Radiol 2017
23
9

Gadolinium and nephrogenic systemic fibrosis: an update.
Alex Weller, Joy L Barber, Oystein E Olsen. Pediatr Nephrol 2014
45
9

Removal of gadolinium by peritoneal dialysis.
M Murashima, H R Drott, D Carlow, L M Shaw, M Milone, M Bachman, D E Tsai, S-L Yang, R D Bloom. Clin Nephrol 2008
10
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.